Veeral Desai is Chief Strategy & Dev. Officer at agilon health, inc. (AGL). They have made 9 open-market trades across 1 company since 2021, most recently 2024-04-15.
CIK 0001855973
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AGL | 502,830 | $42.7M |
Shares reported on the most recent Form 4, priced at the 2024-04-17 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AGL | SELL · 10b5-1 | 2023-05-09 | 2023-05-11 | $26.15 | $118K | -19.0% | -17.1% | -23.6% |
| AGL | SELL · 10b5-1 | 2023-04-19 | 2023-04-21 | $26.83 | $270K | -5.5% | -16.2% | -28.4% |
| AGL | SELL | 2023-03-23 | 2023-03-27 | $28.70 | $4.1M | -8.4% | -14.0% | -41.7% |
| AGL | SELL | 2023-03-16 | 2023-03-17 | $26.09 | $1.6M | +2.8% | +5.3% | -28.2% |
| AGL | SELL | 2022-07-21 | 2022-07-25 | $27.50 | $2.2M | +1.6% | -12.2% | -20.4% |
| AGL | SELL | 2022-07-07 | 2022-07-11 | $25.00 | $8.0M | +4.9% | +3.1% | -17.7% |
| AGL | SELL | 2022-06-24 | 2022-06-28 | $22.50 | $4.8M | +22.2% | +17.4% | +4.6% |
| AGL | SELL | 2022-04-21 | 2022-04-25 | $20.46 | $3.8M | -8.8% | -1.8% | +27.2% |
| AGL | SELL | 2022-04-19 | 2022-04-21 | $22.54 | $9.6M | -3.6% | +0.1% | +37.7% |
| AGL | SELL | 2022-03-16 | 2022-03-18 | $20.41 | $8.1M | +7.5% | -3.4% | -21.4% |
| AGL | SELL | 2021-09-14 | 2021-09-15 | $28.98 | $7.0M | -12.6% | -22.4% | -27.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.